Onco Actu du 18 mai 2017

	1. Biologie
Lab-grown ovaries prove promising in mice [Reuters] Artificial ovaries grown in a lab might someday be available for women with infertility due to cancer treatments or other conditions, a study in mice suggests.
	2.6 Etiologie - Environnement
EU to propose 10-year license renewal for weed killer glyphosate [Reuters] The decision to seek a 10-year rather than a longer approval was also criticized by supporters of the herbicide. The European Crop Protection group called it "short-sighted", saying it pandered to activists.
	5. Traitements
Cutting Down on Cancer Surgeries [Caltech] New microscopy technique could reduce repeat surgeries for breast cancer patients.
	5.10 Traitements - Essais
Researcher with stage 4 cancer launches site to help others navigate clinical trials [STAT] The idea is to radically simplify the process of digging through ClinicalTrials.gov, the government’s compendium of tens of thousands of clinical trials, which is designed more for researchers and physicians than patients.
	5.12 Immunothérapies
Study shows cancer therapy may work in new and unexpected way [Stanford Medicine] In addition to blocking T-cell attacks on cancer, PD-1 signaling also blocks attack by other immune cells called macrophages.
	5.2.3 Pharma - économie
Is Drug R&D Spending Going Up or Down? [In the Pipeline] These are not the results you’d expect if you asked people outside the industry to predict them – in fact, you’d probably get some different estimates from people inside the industry, particularly scientists who have been through layoffs and re-organizations.
	5.5.1.1 ASCO (général) - Industriels
Roche to present new data on personalised medicines and cancer immunotherapies at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting [Roche] 20 Roche medicines are included in more than 190 abstracts during ASCO 2017.
	6.1 Observation
Cancer Prevention & Early Detection, 2017-2018 [ACS] Report notes while there have been improvements in some areas of cancer prevention and early detection, the use of potentially lifesaving measures is sub-optimal.
	6.10 Politiques
Canada Proposes to Amend Drug Pricing Regulations [RAPS] The move comes as the US government is undergoing a similar review of ways to bring down the price of drugs in the US, though one major difference between the neighbors is that Canada’s government has a means by which it can control the price of medicines.
	6.7 DMP, Big Data & applis
Back To The Baseline? Ex-FDA Commish Califf Joins Verily As Advisor [Xconomy] Many signs point to Califf working on Verily’s Baseline project, a multiyear study to monitor and collect data from 10,000 participants.
Robert Califf to join Google life sciences spinoff Verily [STAT] “I’m hoping to offer insights that will allow the company to better tailor its technologies to meet the needs of doctors, other providers, health systems and the patients they serve, and to drive evidence-based approaches that will enable continuous learning and improvement.”